(NASDAQ: CERS) Cerus's forecast annual revenue growth rate of 2.2% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.6%.
Cerus's revenue in 2024 is $186,797,000.On average, 1 Wall Street analysts forecast CERS's revenue for 2024 to be $31,416,296,243, with the lowest CERS revenue forecast at $31,416,296,243, and the highest CERS revenue forecast at $31,416,296,243. On average, 1 Wall Street analysts forecast CERS's revenue for 2025 to be $35,386,387,920, with the lowest CERS revenue forecast at $35,386,387,920, and the highest CERS revenue forecast at $35,386,387,920.
In 2026, CERS is forecast to generate $39,302,094,780 in revenue, with the lowest revenue forecast at $39,302,094,780 and the highest revenue forecast at $39,302,094,780.